Fluconazole penetration into the pancreas

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 9, 2000, Pages 2569-2571

  Shrikhande, S ^a   Friess, H ^a   Issenegger, C ^a   Martignoni, M E ^a   Yong, H ^a   Gloor, B ^a   Yeates, R ^a   Kleeff, J ^a   Buchler, M W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; NONHUMAN; PANCREAS; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; DISEASE MODELS, ANIMAL; FLUCONAZOLE; HUMANS; PANCREATIC DISEASES; PANCREATITIS, ACUTE NECROTIZING; RATS;

EID: 0033836294     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.9.2569-2571.2000     Document Type: Article

References (24)

1. Candida in pancreatic infection: A clinical experience
2. Microbiological findings in severe pancreatitis
3. Prognostic factors in pancreatic abscess
4. Surgical management of necrotizing pancreatitis
5. Bacterial contamination of pancreatic necrosis
6. Later complications of acute pancreatitis
7. The penetration of antibiotics into the human pancreas
8. Human pancreatic tissue concentration of bactericidal antibiotics
9. Acute necrotizing pancreatitis: Treatment strategy according to the status of infection - Results of a prospective unicenter trial
10. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat
11. 18F-labeled fluconazole in healthy human subjects by positron emission tomography
12. Early diagnosis of pancreatic infection by computed tomography guided aspiration
13. Antibiotic prophylaxis and delayed surgery improve the outcome in patients with acute necrotizing pancreatitis
14. Fungal infection in acute necrotizing pancreatitis
15. Hyperlipidemia intensifies the course of acute edematous and acute necrotizing pancreatitis in the rat
16. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans
17. Pancreatic abscess
18. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis
19. Factors contributing to fatal outcome after treatment of pancreatic abscess
20. The discovery and mode of action of fluconazole
21. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis
22. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo
23. Early antibiotic treatment in acute necrotizing pancreatitis
24. Infections complicating pancreatitis: Diagnosing, treating, preventing